Company intelligence / Profile preview

Puyer Biopharma

Nantong, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Puyer Biopharma produces and supplies over 300 fine chemicals, APIs, intermediates, nutraceutical ingredients and research reagents for clients globally. Clinical results not applicable as they are a manufacturing and custom synthesis provider

Modalities: Small moleculePeptidesHormonesAmino acid derivativesAPIs
Industry: Contract Manufacturing Organization

Partnerships

Partnerships with many Chinese manufacturers and dealerslong-term business relationships globally (Asia-Pacific, Europe, Americas, Middle East)

Beyond the preview

Go deeper on Puyer Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puyer Biopharma.

Explore the full profile